pLenti-CMV-Blast-DNTGFBR2-HA
(Plasmid
#130888)
-
PurposeExpresses dominant negative mutant human TGFBR2
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 130888 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepLenti CMV Blast DEST
-
Backbone manufacturerAddgene plasmid #17451
- Backbone size w/o insert (bp) 9331
- Total vector size (bp) 8321
-
Modifications to backboneGateway Cloning
-
Vector typeMammalian Expression
-
Selectable markersBlasticidin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameTGFBR2
-
SpeciesH. sapiens (human)
-
Insert Size (bp)573
-
MutationDominant Negative receptor lacking cytosolic catalytic domain. First 573 bp of human TGFBR2 cDNA (variant 2)
-
GenBank IDNM_003242.5
-
Entrez GeneTGFBR2 (a.k.a. AAT3, FAA3, LDS1B, LDS2, LDS2B, MFS2, RIIC, TAAD2, TBR-ii, TBRII, TGFR-2, TGFbeta-RII, tbetaR-II)
- Promoter CMV
-
Tag
/ Fusion Protein
- HA-tag (C terminal on insert)
Cloning Information
- Cloning method Gateway Cloning
- 5′ sequencing primer CMV Forward (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pLenti-CMV-Blast-DNTGFBR2-HA was a gift from Gian-Paolo Dotto (Addgene plasmid # 130888 ; http://n2t.net/addgene:130888 ; RRID:Addgene_130888) -
For your References section:
Dualism of FGF and TGF-beta Signaling in Heterogeneous Cancer-Associated Fibroblast Activation with ETV1 as a Critical Determinant. Bordignon P, Bottoni G, Xu X, Popescu AS, Truan Z, Guenova E, Kofler L, Jafari P, Ostano P, Rocken M, Neel V, Dotto GP. Cell Rep. 2019 Aug 27;28(9):2358-2372.e6. doi: 10.1016/j.celrep.2019.07.092. 10.1016/j.celrep.2019.07.092 PubMed 31461652